3340 results

MedAlliance SELUTION SLR Receives Second FDA IDE Approval

09 Aug 2022

iFR-SWEDEHEART: iFR vs FFR-Guided Coronary Revascularisation

04 Nov 2021

Nicola Ryan reviews the iFR Swedeheart multicenter, randomized, controlled, open-label clinical trial using the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) for enrolment randomisation and follow up. At one year follow up iFR guided revascularisation was shown to be non-inferior to FFR guided revascularisation, these results...

Author

Nicola Ryan

SWISS-APERO: a randomized trial of the amulet versus watchman FLX devices for left atrial appendage closure

04 Nov 2021

The SWISS-APERO is a prospective, investigator-initiated, randomized, multi-center, and clinical trial designed to compare the Amulet and Watchman (2.5 and FLX) devices in a head-to-head fashion.

Author

Francesco Costa

GUIDE-HF: can continuous pulmonary artery pressure monitoring improve heart failure management?

09 Nov 2021

The main goal of the randomized GUIDE-HF trial was to assess the ability of continuous PAP monitoring to improve outcomes in patients with heart failure NYHA class II-IV and a HF hospitalization within previous 12 months or elevated BNP/NT-proBNP. 

Author

Dejan Milasinovic

First Patient Enrolled in SELUTION SLR IDE BTK Study

08 Jun 2022

Dapagliflozin in acute myocardial infarction: Cardiometabolic benefits without impact on cardiovascular death or heart failure hospitalization: The jury is still out

14 Nov 2023

Luis Ortega Paz provides his take on DAPA-MI - A registry-based randomized trial of dapagliflozin in patient with acute myocardial infarction without diabetes, which was presented by Stefan James at AHA 2023 in Philadelphia.

Author

Luis Ortega-Paz

NOTION-3 - Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation

01 Sep 2024

Make the most of the insights from Jacob Thomsen Loenborg’s interview with Chiara De Biase and Ali Nazmi Calik’s article to capture the key takeaways from this trial, simultaneously published in the NEJM, presented at the ESC Congress 2024 in London.

Author

Chiara De Biase

Author

Jacob Lønborg

Author

Ali Nazmi Calik

SEISMIC-HF I - Exploring non-invasive methods for monitoring intracardiac filling pressures

16 Nov 2024

Luis Ortega provides his take on the SEISMIC-HF I study presented by Liviu Klein at AHA 2024, in Chicago.

Author

Luis Ortega-Paz

Singapore approves novel Hydra TAVI system

28 Oct 2024

Hybrid step-by-step approach to perform a Robotic DK Crush PCI

28 Jan 2022

View the case of this 65-year-old male patient who was staged for R-PCI of a Medina 1,1,1 distal left main lesion, and discover how the authors used a hybrid robotic and manual approach to perform a DK crush procedure using the second-generation R-PCI device.

Why hypertension is a major unresolved problem

02 Oct 2024

Explore the global challenge of hypertension, affecting one in three adults, and the strategies for screening, diagnosis, and management, including lifestyle modifications, pharmacotherapy, and device-based treatments, as outlined by Sofie Brouwers.

Author

Sofie Brouwers

Performing BASILICA: a step-by-step guide to prevent coronary obstruction during TAVI

05 Aug 2025

Author

Ahmed Abdelhafez

Author

Mohamed Abdel-Wahab

Commissural alignment during TAVI

13 Sep 2023

As lifetime management of aortic valve disease patients undergoing TAVI is gaining increased attention, this article sought to summarize the principal idea and possible technical implementation of commissural alignment with current generation transcatheter heart valves (THVs).

Author

Ahmed Abdelhafez

Author

Johannes Wilde

Author

Mohamed Abdel-Wahab

Insights from the Corevalve US Pivotal and SURTAVI trials

05 Apr 2022

Pierre Deharo and Giuseppe Di Gioia provide their take on this analysis of the 5 years incidence, outcomes and predictors of hemodynamic SVD in patients undergoing TAVI and surgery from the Corevalve US Pivotal and SURTAVI trials.

Author

Pierre Deharo

Author

Giuseppe Di Gioia

TRILUMINATE pivotal: A landmark randomized clinical trial of transcatheter tricuspid valve edge-to-edge repair for tricuspid regurgitation

04 Mar 2023

Jonathan Curio and Alex Sticchi provide their take on this clinical trial which was presented by Paul Sorajja at the American College of Cardiology Scientific Session (ACC.23/WCC).

Author

Alessandro Sticchi

Author

Jonathan Curio

Transcatheter aortic valve replacement in small aortic annuli: Results from the FRANCE-TAVI registry

17 Sep 2022

Mirvat Alasnag provides her take on the outcomes of small annuli sub-study from the FRANCE-TAVI Registry which included 1,195 patients. This trial was presented by Walid Ben-Ali at TCT 2022.

Author

Mirvat Alasnag

We CARE 2022

19 May 2022

Paris, France. 19 May 2022. We CARE, a joint initiative of PCR and Stent – Save a Life!, dedicated to restoring faith in cardiovascular healthcare and increasing awareness of the importance of timely and accessible treatment, is presenting a first study at EuroPCR 2022: a UK...

Preventive PCI or medical therapy alone for atherosclerotic coronary vulnerable plaques (PREVENT)

08 Apr 2024

Ali Nazmi Calik provides his take on the results of the PREVENT trial presented at ACC.24 in Atlanta.

Author

Ali Nazmi Calik

A review of the 2024 ESC Guidelines on elevated blood pressure and hypertension

13 Nov 2024

Lucas Lauder and Felix Mahfoud provide a summary of the ESC Guidelines on elevated blood pressure and hypertension presented by John William McEvoy and Rhian Touyz at ESC Congress 2024 in London.

Author

Lucas Lauder

Author

Felix Mahfoud

The CLEAR SYNERGY (OASIS 9) Trial: A 2x2 factorial randomized controlled trial of colchicine versus placebo and spironolactone versus placebo in patients with myocardial infarction

18 Nov 2024

Mirvat Alasnag provides her take on the CLEAR SYNERGY trial presented by Sanjit S Jolly at AHA 2024 in Chicago.

Author

Mirvat Alasnag